Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1903910rdf:typepubmed:Citationlld:pubmed
pubmed-article:1903910lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0027573lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C1301886lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0427978lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0055011lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C2827787lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C1710706lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0281162lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:1903910lifeskim:mentionsumls-concept:C0441665lld:lifeskim
pubmed-article:1903910pubmed:issue3lld:pubmed
pubmed-article:1903910pubmed:dateCreated1991-7-2lld:pubmed
pubmed-article:1903910pubmed:abstractTextWe studied the susceptibilities of 77 strains of Neisseria gonorrhoeae to four antibiotics: cefpodoxime, ceftriaxone, penicillin, and tetracycline. All strains were susceptible to ceftriaxone. Cefpodoxime MICs (range, 0.001 to 0.125 micrograms/ml) were parallel to and approximately four times those of ceftriaxone, and all strains will probably be considered susceptible to cefpodoxime. Disk diffusion zone diameters for cefpodoxime ranged from 35 to 57 mm. Of the strains, 32% were penicillin resistant and 51% were tetracycline resistant (MIC, greater than or equal to 2 micrograms/ml). Susceptibility measurements were consistent for disk diffusion zone diameter and MIC, with an overall agreement of 215 of 225 (96%) for ceftriaxone, penicillin, and tetracycline combined. On the basis of these in vitro data, cefpodoxime should be evaluated in the treatment of gonorrhea.lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:languageenglld:pubmed
pubmed-article:1903910pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:citationSubsetIMlld:pubmed
pubmed-article:1903910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1903910pubmed:statusMEDLINElld:pubmed
pubmed-article:1903910pubmed:monthMarlld:pubmed
pubmed-article:1903910pubmed:issn0066-4804lld:pubmed
pubmed-article:1903910pubmed:authorpubmed-author:FeketeTTlld:pubmed
pubmed-article:1903910pubmed:authorpubmed-author:CundyK RKRlld:pubmed
pubmed-article:1903910pubmed:authorpubmed-author:WoodwellJJlld:pubmed
pubmed-article:1903910pubmed:issnTypePrintlld:pubmed
pubmed-article:1903910pubmed:volume35lld:pubmed
pubmed-article:1903910pubmed:ownerNLMlld:pubmed
pubmed-article:1903910pubmed:authorsCompleteYlld:pubmed
pubmed-article:1903910pubmed:pagination497-9lld:pubmed
pubmed-article:1903910pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:meshHeadingpubmed-meshheading:1903910-...lld:pubmed
pubmed-article:1903910pubmed:year1991lld:pubmed
pubmed-article:1903910pubmed:articleTitleSusceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.lld:pubmed
pubmed-article:1903910pubmed:affiliationDepartment of Internal Medicine, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140.lld:pubmed
pubmed-article:1903910pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1903910pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1903910pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1903910lld:pubmed